Report Content
- Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
- Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach - Segmental Market Analysis
2.5.2 Top-Down Approach - Parent Market Analysis
- Executive Summary
- Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter''s Five Force Analysis
- Immunoassay Market, By End User
5.1 Introduction
5.2 Hospitals
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Clinical Laboratories
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Blood Banks
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Academic Research Centres
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Pharmaceutical Companies
5.6.1 Market Overview
5.6.2 Market Size and Forecast
5.7 Biotechnology Companies
5.7.1 Market Overview
5.7.2 Market Size and Forecast
5.8 Others
5.8.1 Market Overview
5.8.2 Market Size and Forecast
- Immunoassay Market, By Technology
6.1 Introduction
6.2 ELISA
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Fluorescence
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Colorimetric
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Chemiluminescence
6.5.1 Market Overview
6.5.2 Market Size and Forecast
6.6 Rapid Test
6.6.1 Market Overview
6.6.2 Market Size and Forecast
6.7 Western Blot
6.7.1 Market Overview
6.7.2 Market Size and Forecast
6.8 ELISPOT
6.8.1 Market Overview
6.8.2 Market Size and Forecast
6.9 PCR
6.9.1 Market Overview
6.9.2 Market Size and Forecast
- Immunoassay Market, By Application
7.1 Introduction
7.2 Infectious Disease
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Endocrinology
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Cardiology
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Oncology
7.5.1 Market Overview
7.5.2 Market Size and Forecast
7.6 Haematology
7.6.1 Market Overview
7.6.2 Market Size and Forecast
- Immunoassay Market, By Product & Services
8.1 Introduction
8.2 Reagents & Kits
8.2.1 Market Overview
8.2.2 Market Size and Forecast
8.3 Analysers
8.3.1 Market Overview
8.3.2 Market Size and Forecast
8.4 Software Services
8.4.1 Market Overview
8.4.2 Market Size and Forecast
- Immunoassay Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 North America Immunoassay, By End User
9.2.2 North America Immunoassay, By Technology
9.2.3 North America Immunoassay, By Application
9.2.4 North America Immunoassay, By Product & Services
9.3 Europe
9.3.1 Europe Immunoassay, By End User
9.3.2 Europe Immunoassay, By Technology
9.3.3 Europe Immunoassay, By Application
9.3.4 Europe Immunoassay, By Product & Services
9.4 Asia-Pacific
9.4.1 Asia-Pacific Immunoassay, By End User
9.4.2 Asia-Pacific Immunoassay, By Technology
9.4.3 Asia-Pacific Immunoassay, By Application
9.4.4 Asia-Pacific Immunoassay, By Product & Services
9.5 Rest of the World
9.5.1 Rest of the World Immunoassay, By End User
9.5.2 Rest of the World Immunoassay, By Technology
9.5.3 Rest of the World Immunoassay, By Application
9.5.4 Rest of the World Immunoassay, By Product & Services
- Competitive Insights
10.1 Key Insights
10.2 Company Market Share Analysis
10.3 Strategic Outlook
10.3.1 Mergers & Acquisitions
10.3.2 New Product Development
10.3.3 Portfolio/Production Capacity Expansions
10.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
10.3.5 Others
- Company Profiles
11.1 Roche Diagnostics Limited
11.1.1 Company Overview
11.1.2 Product/Service Landscape
11.1.3 Financial Overview
11.1.4 Recent Developments
11.2 Siemens Healthcare
11.2.1 Company Overview
11.2.2 Product/Service Landscape
11.2.3 Financial Overview
11.2.4 Recent Developments
11.3 Abbott Laboratories
11.3.1 Company Overview
11.3.2 Product/Service Landscape
11.3.3 Financial Overview
11.3.4 Recent Developments
11.4 Beckman Coulter
11.4.1 Company Overview
11.4.2 Product/Service Landscape
11.4.3 Financial Overview
11.4.4 Recent Developments
11.5 Ortho Clinical Diagnostics
11.5.1 Company Overview
11.5.2 Product/Service Landscape
11.5.3 Financial Overview
11.5.4 Recent Developments
11.6 BioMrieux
11.6.1 Company Overview
11.6.2 Product/Service Landscape
11.6.3 Financial Overview
11.6.4 Recent Developments
11.7 Bio-Rad Laboratories Inc.
11.7.1 Company Overview
11.7.2 Product/Service Landscape
11.7.3 Financial Overview
11.7.4 Recent Developments
11.8 Alere Inc.
11.8.1 Company Overview
11.8.2 Product/Service Landscape
11.8.3 Financial Overview
11.8.4 Recent Developments
11.9 Sysmex Corporation
11.9.1 Company Overview
11.9.2 Product/Service Landscape
11.9.3 Financial Overview
11.9.4 Recent Developments
11.10 Becton, Dickinson & Company
11.10.1 Company Overview
11.10.2 Product/Service Landscape
11.10.3 Financial Overview
11.10.4 Recent Developments